Suppr超能文献

肠炎沙门氏菌突变体作为候选疫苗的免疫原性及其对鸡沙门氏菌病的保护效果。

Immunogenicity of a Salmonella Enteritidis mutant as vaccine candidate and its protective efficacy against salmonellosis in chickens.

作者信息

Nandre Rahul M, Chaudhari Atul A, Matsuda Kiku, Lee John Hwa

机构信息

College of Veterinary Medicine, Chonbuk National University, Jeonju 561-756, South Korea.

出版信息

Vet Immunol Immunopathol. 2011 Dec 15;144(3-4):299-311. doi: 10.1016/j.vetimm.2011.08.015. Epub 2011 Aug 26.

Abstract

A novel Salmonella Enteritidis (SE) vaccine candidate strain, JOL919 was constructed by deleting the lon and cpxR genes from a wild-type SE using an allelic exchange method. The study was carried out to evaluate the strain as a vaccine candidate against salmonellosis. The strain showed the enhanced macrophage invasion, early bacterial clearance and higher immune responses as compared to the other mutants, JOL917 (Δlon) and JOL918 (ΔcpxR), and the wild type. In further analysis, the chickens immunized with JOL919 showed a significant increase in plasma IgG and intestinal secretory IgA levels, which was an indication of robust humoral and mucosal immune responses induced by the candidate. The lymphocyte proliferation response and CD45(+)CD3(+) T cells, associated with an activation of T helper and cytotoxic cells, were also significantly increased in the immunized group, which indicated that the candidate also induced cellular immune responses. The immune cell influx into caecal tissues analyzed by immunohistochemistry showed that CD8(+) T cells were predominated in the immunized group, suggesting that the candidate can clear the invaded pathogen in the intestines by a more direct way involving cytotoxic activity. By the examination of the protection efficacy measured by observations of gross lesions in the organs and bacterial recovery, the candidate can provide an efficient protection upon virulent challenge.

摘要

一种新型肠炎沙门氏菌(SE)候选疫苗株JOL919,是通过等位基因交换方法从野生型SE中删除lon和cpxR基因构建而成。开展该研究以评估该菌株作为抗沙门氏菌病候选疫苗的效果。与其他突变株JOL917(Δlon)和JOL918(ΔcpxR)以及野生型相比,该菌株表现出增强的巨噬细胞侵袭能力、早期细菌清除能力和更高的免疫反应。在进一步分析中,用JOL919免疫的鸡血浆IgG和肠道分泌型IgA水平显著升高,这表明该候选疫苗诱导了强大的体液免疫和黏膜免疫反应。免疫组中与辅助性T细胞和细胞毒性细胞激活相关的淋巴细胞增殖反应以及CD45(+)CD3(+) T细胞也显著增加,这表明该候选疫苗还诱导了细胞免疫反应。通过免疫组织化学分析盲肠组织中的免疫细胞流入情况,结果显示免疫组中CD8(+) T细胞占主导地位,这表明该候选疫苗可以通过涉及细胞毒性活性的更直接方式清除肠道中入侵的病原体。通过观察器官中的大体病变和细菌回收情况来衡量保护效果,该候选疫苗在受到强毒株攻击时可提供有效的保护。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验